abstract |
The present invention relates to novel crystalline forms of atorvastatin calcium (2: 1), designated herein as polymorphic forms X, A, B1, B2, C, D and E. Furthermore, the present invention relates to a method for producing these crystals, and a pharmaceutical composition containing these crystals. |